Arizona State Retirement System Sells 815 Shares of Envista Holdings Co. (NYSE:NVST)

Arizona State Retirement System trimmed its holdings in shares of Envista Holdings Co. (NYSE:NVST) by 1.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 45,796 shares of the company’s stock after selling 815 shares during the quarter. Arizona State Retirement System’s holdings in Envista were worth $1,102,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. raised its position in shares of Envista by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 16,223,171 shares of the company’s stock valued at $452,302,000 after buying an additional 62,463 shares in the last quarter. Ariel Investments LLC raised its position in shares of Envista by 4.3% in the 3rd quarter. Ariel Investments LLC now owns 5,335,578 shares of the company’s stock valued at $148,756,000 after buying an additional 218,461 shares in the last quarter. Alliancebernstein L.P. raised its position in shares of Envista by 50.5% in the 4th quarter. Alliancebernstein L.P. now owns 4,209,467 shares of the company’s stock valued at $141,733,000 after buying an additional 1,412,915 shares in the last quarter. Macquarie Group Ltd. raised its position in shares of Envista by 14.4% in the 1st quarter. Macquarie Group Ltd. now owns 4,157,392 shares of the company’s stock valued at $169,954,000 after buying an additional 524,622 shares in the last quarter. Finally, Eaton Vance Management raised its position in shares of Envista by 7.2% in the 1st quarter. Eaton Vance Management now owns 2,187,720 shares of the company’s stock valued at $106,563,000 after buying an additional 147,127 shares in the last quarter.

Envista Trading Down 0.1 %

NYSE:NVST opened at $19.16 on Tuesday. The firm’s fifty day moving average is $21.45 and its 200-day moving average is $23.09. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.90 and a current ratio of 2.23. Envista Holdings Co. has a 52 week low of $18.95 and a 52 week high of $39.28. The firm has a market cap of $3.29 billion, a P/E ratio of -31.41, a P/E/G ratio of 3.57 and a beta of 1.35.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $0.29 EPS for the quarter, missing analysts’ consensus estimates of $0.33 by ($0.04). Envista had a negative net margin of 3.90% and a positive return on equity of 6.31%. The firm had revenue of $645.60 million during the quarter, compared to the consensus estimate of $638.37 million. During the same period in the prior year, the company posted $0.52 earnings per share. The company’s revenue for the quarter was down 2.3% compared to the same quarter last year. Equities analysts expect that Envista Holdings Co. will post 1.43 earnings per share for the current year.

Wall Street Analyst Weigh In

NVST has been the subject of a number of research analyst reports. UBS Group initiated coverage on shares of Envista in a research report on Friday, January 5th. They set a “neutral” rating and a $26.00 price objective for the company. TheStreet cut shares of Envista from a “c” rating to a “d+” rating in a research report on Wednesday, February 7th. SVB Leerink started coverage on shares of Envista in a research report on Monday, February 26th. They set an “underperform” rating and a $19.00 price objective for the company. William Blair lowered shares of Envista from an “outperform” rating to a “market perform” rating in a report on Thursday, February 8th. Finally, Leerink Partnrs reissued an “underperform” rating on shares of Envista in a report on Monday, February 26th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $29.60.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.